The effect of E-5842, a sigma receptor ligand and potential atypical antipsychotic, on Fos expression in rat forebrain.

We examined the ability of E-5842 (4-(4-fluorophenil)-1,2,3,6- tetrahydro-1-[4-(1,2,4-triazol-1-il)butyl] pyridine citrate), a sigma receptor ligand, to increase Fos protein expression in regions of rat forebrain. An acute administration of E-5842 increased levels of Fos in the medial prefrontal cortex and the nucleus accumbens, without affecting the levels of the protein in the striatum, an effect very similar to that of clozapine. Our results suggest that E-5842 may be an atypical antipsychotic with low propensity to produce extrapyramidal side-effects.

[1]  A. Deutch,et al.  Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[2]  H. Fibiger,et al.  Receptor mechanisms mediating clozapine-inducedc-fos expression in the forebrain , 1995, Neuroscience.

[3]  C. Marsden,et al.  Dopamine D3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D3 receptor antagonist GR103691 with typical and atypical neuroleptics. , 1996, European journal of pharmacology.

[4]  S. Gershon,et al.  Clozapine--a potential antipsychotic agent without extrapyramidal manifestations. , 1974, Current therapeutic research, clinical and experimental.

[5]  M. Korner,et al.  A brain-specific transcription activator , 1989, Neuron.

[6]  H. Fibiger,et al.  Effects of Olanzapine on Regional C-Fos Expression in Rat Forebrain , 1996, Neuropsychopharmacology.

[7]  D. Weinberger,et al.  Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. , 1986, Archives of general psychiatry.

[8]  H. Fibiger,et al.  Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. , 1994, The Journal of pharmacology and experimental therapeutics.

[9]  D. Rujescu,et al.  Induction of c-fos gene expression by the selective sigma receptor ligand EMD 57445 in rat brain , 1996, European Neuropsychopharmacology.

[10]  T. Curran,et al.  Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. , 1991, Annual review of neuroscience.

[11]  M. Dragunow,et al.  D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons , 1990, Neuroscience.

[12]  Daniel R. Weinberger,et al.  Schizophrenia and the frontal lobe , 1988, Trends in Neurosciences.

[13]  R. Baldessarini,et al.  Clozapine. A novel antipsychotic agent. , 1991, The New England journal of medicine.

[14]  A. Deutch,et al.  Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action , 1992, Molecular and Cellular Neuroscience.

[15]  G Honigfeld,et al.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. , 1988, Archives of general psychiatry.

[16]  T. Curran,et al.  Expression of c-fos protein in brain: metabolic mapping at the cellular level. , 1988, Science.

[17]  A I Basbaum,et al.  Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[18]  H. Fibiger,et al.  Neuroleptics increase C-FOS expression in the forebrain: Contrasting effects of haloperidol and clozapine , 1992, Neuroscience.

[19]  Jeannette C. Miller.  Induction of c‐fos mRNA Expression in Rat Striatum by Neuroleptic Drugs , 1990, Journal of neurochemistry.

[20]  A. Fink-Jensen,et al.  Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebrain , 1994, Neuroscience Letters.

[21]  B. M. Cohen,et al.  Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[22]  B. Bunney,et al.  Mechanisms of action of atypical antipsychotic drugs Implications for novel therapeutic strategies for schizophrenia , 1991, Schizophrenia Research.